Company Analysis Andlauer Healthcare Group Inc
1. Summary
Advantages
- Dividends (1.03%) are higher than the sector average (0%).
- The stock's return over the last year (36.01%) is higher than the sector average (-0.7953%).
- The company's current efficiency (ROE=14.32%) is higher than the sector average (ROE=0%)
Disadvantages
- Price (38.75 $) is higher than fair price (20.59 $)
- Current debt level 26% has increased over 5 years from 22.35%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Andlauer Healthcare Group Inc | Index | ||
|---|---|---|---|
| 7 days | 0% | -0.1% | -0.6% |
| 90 days | 47.7% | -2.6% | 5.7% |
| 1 year | 36% | -0.8% | 9% |
ANDHF vs Sector: Andlauer Healthcare Group Inc has outperformed the "" sector by 36.81% over the past year.
ANDHF vs Market: Andlauer Healthcare Group Inc has outperformed the market by 27.03% over the past year.
Stable price: ANDHF is not significantly more volatile than the rest of the market on "USA Stocks" over the last 3 months, with typical variations of +/- 5% per week.
Long period: ANDHF with weekly volatility of 0.6926% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (38.75 $) is higher than the fair price (20.59 $).
Price is higher than fair: The current price (38.75 $) is 46.9% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (25.4) is higher than that of the sector as a whole (0).
P/E vs Market: The company's P/E (25.4) is higher than that of the market as a whole (0).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (3.8) is higher than that of the sector as a whole (0).
P/BV vs Market: The company's P/BV (3.8) is higher than that of the market as a whole (0).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.52) is higher than that of the sector as a whole (0).
P/S vs Market: The company's P/S indicator (2.52) is higher than that of the market as a whole (0).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (10.66) is higher than that of the sector as a whole (0).
EV/Ebitda vs Market: The company's EV/Ebitda (10.66) is higher than that of the market as a whole (0).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 14.19% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (14.19%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0%).
5.4. ROE
ROE vs Sector: The company's ROE (14.32%) is higher than that of the sector as a whole (0%).
ROE vs Market: The company's ROE (14.32%) is higher than that of the market as a whole (0%).
5.5. ROA
ROA vs Sector: The company's ROA (9.35%) is higher than that of the sector as a whole (0%).
ROA vs Market: The company's ROA (9.35%) is higher than that of the market as a whole (0%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 1.03% is higher than the average for the sector '0%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 1.03% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 1.03% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (25.94%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
